Skip to main content

Core value dossiers for medical technologies

Essential tool to support market access and marketing efforts through the lifecycle of the product

Learn more
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Bi-weekly snapshot of market access and HEOR project work at MTRC

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients to understand the potential scope of our support better.

From the week of the 16th of December, we are planning to work on 20 projects, including:

Reimbursement

  1. Finalizing reimbursement and procedure volume analysis project for multiple technologies in obstetrics and gynecology in France, Germany, Italy, and Spain
  2. Finalizing policy analysis project, including qualitative interviews, in the obstetrics and gynecology field in Austria, Denmark, Finland, Norway and Sweden 
  3. Delivering educational materials on the reimbursement system in the Netherlands
  4. Working on the reimbursement analysis for therapeutic drug monitoring in England and France
  5. Working on the market access strategy for parenteral drug delivery systems in outpatient specialist and home-based care in Austria, Belgium, Czech Republic, Denmark, England, Finland, France, Germany, Greece, Italy, Netherlands, Norway, Poland, Spain, Sweden
  6. Finalizing high-level overview of market access pathways for ostomy products in France and Germany 
  7. Working on the reimbursement analysis for embolization procedures in different indications in England, France, Germany, Italy and Spain
  8. Initiating work on the reimbursement analysis for treatment of endoleak following endovascular treatment of aortic aneurysm in England, France, Germany, and Italy
  9. Working on an overview of payment mechanisms for hospital procedures and devices in the Czech Republic, Denmark, Hungary, the Netherlands, Norway, Romania
  10. Initiating work on the reimbursement analysis for remote monitoring in the cardiology field in Germany and the Netherlands
  11. Initiating work on reimbursement analysis for cardiovascular technology in Belgium

HEOR

  1. Working on the development of an HTA national submission dossier in Sweden 
  2. Finalizing the development of a health economic model for neurovascular technology in Belgium, England, France, Germany, Italy, and Spain 
  3. Finalizing the development of a health economic model for neuromonitoring technology in England
  4. Working on the development of a health economic model for in-vitro diagnostic tests in neurology disease areas in England, France, Germany, Italy, and Spain 
  5. Working on the Evidence Gap Analysis for two technologies in the nephrology field 
  6. Finalizing the development of the reimbursement application for technology in the neurovascular field in Ireland 
  7. Working on the development of the reimbursement application for technology in the neurovascular field in Hungary 
  8. Working on the update of adaptation of the global value dossiers for several technologies in cardio-renal and infectious disease space to European settings 
  9. Working on the development of a value dossier for a urinary technology in the EMEA region

Let us know if you need any market access or HEOR support for your medical technology in Europe.